Article Name Europe
Magnetom Flow RT Pro Edition enables adaptive radiotherapy with AI-powered imaging, helium-independent cooling, and simplified installation near linear accelerators for enhanced patient care.
06th May, 2025
UK hospital becomes first globally to treat patient with new module for online adaptive radiotherapy
05th May, 2025
New QA system aims to enhance geometric accuracy in MR-guided radiation therapy and stereotactic planning
05th May, 2025
ESTRO debut highlights breakthrough in collision-free, non-coplanar beam planning through surface-guided technology integration
05th May, 2025
A new technology marks a turning point in the treatment of early-stage breast cancer
30th April, 2025
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent
29th April, 2025
The minimally invasive MINT® procedure offers a novel, sutureless solution for managing intraocular pressure in glaucoma patients.
18th April, 2025
Clinicians across the United Kingdom can now access Eko's advanced digital stethoscopes, auscultation accessories, and AI-supported tools via EkoHealth.com and Amazon UK.
16th April, 2025
New TS1200 model supports up to 300 lbs, offering hospitals a more efficient, scalable solution for surgical instrument transport and storage.
14th April, 2025
Hours, Not Days: EU Approval Accelerates 5-Hour Pathogen ID for Critical Cases. Molecular Fingerprinting: AI-Powered ‘DNA Barcode’ Spots 200+ Species, Including Uncultivable Pathogens. Hospital Laboratories Across Europe Now Have Immediate Access To a Fully Certified, Untargeted Molecular Diagnostics Platform.
11th April, 2025
Robotic-Assisted Platform Enhances Intraoperative Radiation Therapy for Neuro-Oncology and Breast Cancer Treatments
10th April, 2025
The collaboration is in line with Orexo's strategy to broaden the use of its powder-based drug delivery technology, AmorphOX®.
10th April, 2025
Collaboration Enhances Cancer Diagnostics by Integrating Advanced AI into Unified Imaging Workflows
09th April, 2025
• Osteopore secures European Union Medical Device Regulation (EU MDR) approval to supply its cutting-edge custom orthopaedic and cranial implants. • EU MDR approval unlocks opportunities to offer high-value, custom implants to Europe, in addition to off-the-shelf implants, introducing new revenue streams. • Regulatory clearance validates Osteopore’s orthopaedic and cranial products in Europe, strengthening the Company’s positioning in the market. • The European orthopaedic market is projected to grow at a CAGR of 3.3% (2029),while the cranial implant market is expected to grow at a CAGR of 9.4% (2030).
09th April, 2025
Advanced Machine Learning Tool Integrates with Shoulder Planning App to Personalize Surgical Predictions
08th April, 2025
Strategic collaboration extends TOOsonix's reach into Poland, addressing skin diseases for a population of over 37 million.
31st March, 2025
New results from the VERIFI study show Immunovia's test accurately detects 77% of early-stage cases and maintains strong specificity across diverse high-risk groups—strengthening commercial launch plans for Q3 2025.
25th March, 2025
Innovative software enhances MRI scan quality, reduces scan times by up to 80%, and optimizes radiology workflows without requiring hardware upgrades.
17th March, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer